Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3182)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 14, 2024 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Soresi M, Giannitrapani L. Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(30): 3541-3547 [PMID: 39193573 DOI: 10.3748/wjg.v30.i30.3541] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i30/3541.htm |
| Number | Citing Articles |
| 1 |
Anmol Singh, Aalam Sohal, Akash Batta. GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis. World Journal of Gastroenterology 2024; 30(48): 5205-5211 doi: 10.3748/wjg.v30.i48.5205
|
| 2 |
Bryan A. Priego-Parra, Rocío Gallego-Durán, Berenice M. Román-Calleja, José Antonio Velarde-Ruiz Velasco, Manuel Romero-Gómez, Jordi Gracia-Sancho. Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease. Trends in Endocrinology & Metabolism 2025; doi: 10.1016/j.tem.2025.03.006
|
| 3 |
Adrián Cortés-Martín, Julio Plaza-Diaz. Exploring the therapeutic potential of glucagon-like peptide 1 agonists in metabolic disorders. World Journal of Gastroenterology 2025; 31(4): 101436 doi: 10.3748/wjg.v31.i4.101436
|
| 4 |
Yilmaz Gunes. A brief approach to hypertension in type 2 diabetes mellitus. Exploration of Endocrine and Metabolic Diseases 2025; doi: 10.37349/eemd.2025.101422
|
| 5 |
Mo-Wei Kong, Yang Yu, Ying Wan, Yu Gao, Chun-Xiang Zhang. Glucagon-like peptide-1 receptor agonists: Exploring the mechanisms from glycemic control to treatment of multisystemic diseases. World Journal of Gastroenterology 2024; 30(36): 4036-4043 doi: 10.3748/wjg.v30.i36.4036
|